CONTINUOUS 5-DAY REGIONAL CHEMOTHERAPY BY 5-FLUOROURACIL IN COLON-CARCINOMA - PHARMACOKINETIC EVALUATION

被引：35

作者：

BOUBLIL, JL

MILANO, G

KHATER, R

BOURRY, J

THYSS, A

BRUNETON, JN

RENEE, N

PHILIP, C

NAMER, M

机构：

[1] CTR ANTOINE LACASSAGNE,PHARMACOKINET UNIT,36 VOIE ROMAINE,F-06054 NICE,FRANCE

[2] CTR ANTOINE LACASSAGNE,DEPT MED ONCOL,F-06054 NICE,FRANCE

[3] CTR ANTOINE LACASSAGNE,STAT UNIT,F-06054 NICE,FRANCE

来源：

关键词：

D O I：

10.1038/bjc.1985.142

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：15 / 20

页数：6

共 22 条

[1] ACKERMAN NB, 1969, SURGERY, V66, P1067
[2] ANSFIELD FJ, 1971, CANCER-AM CANCER SOC, V28, P1147, DOI 10.1002/1097-0142(1971)28:5<1147::AID-CNCR2820280510>3.0.CO
[3] 2-L
[4] CONTROLLED BLOCKING OF HEPATIC-ARTERY FLOW WITH ENZYMATICALLY DEGRADABLE MICROSPHERES COMBINED WITH ONCOLYTIC DRUGS
ARONSEN, KF
HELLEKANT, C
HOLMBERG, J
ROTHMAN, U
TEDER, H
[J]. EUROPEAN SURGICAL RESEARCH, 1979, 11 (02) : 99 - 106
[5] CLINICAL PHARMACOKINETICS OF COMMONLY USED ANTI-CANCER DRUGS
BALIS, FM
HOLCENBERG, JS
BLEYER, WA
[J]. CLINICAL PHARMACOKINETICS, 1983, 8 (03) : 202 - 232
[6] BLACKSHEAR PJ, 1972, SURG GYNECOL OBSTETR, V134, P51
[7] CHEN HSG, 1980, CANCER TREAT REP, V64, P31
[8] CHRISTOPHIDIS N, 1979, CLIN CHEM, V25, P83
[9] DAVIS HL, 1982, CANCER-AM CANCER SOC, V50, P2638
[10] ENSMINGER DW, 1983, P ASCO, V2, pC98